Loading asset research
Enliven Therapeutics Inc. Common Stock
ELVNNasdaq · USD · StocksQuote as of · Exchange session not verified$54.29
-3.45%
Today
ELVN
Loading 1D prices…
Market cap
$4B
Volume
995.8K
52w high
$62.3252w low
$14.78Company profile
Enliven Therapeutics Inc. Common Stock
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its clinical programs comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a central nervous system (CNS) penetrant and irreversible human epidermal growth factor receptor 2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 mutant tumors. The company was founded in 2019 and is headquartered in Boulder, Colorado.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Boulder, CO, United States
Employees
67
Fiscal year end
1231
CIK
1672619
Session & valuation
Open$57.00
Previous close$56.23
Day high$57.00
Day low$54.12
30-day avg. volume1M
Outstanding shares73.3M
Diluted EPS-$1.83
Latest annual period
P/E (trailing)-29.67
P/E (forward)-23.23
Price / book4.45
Beta0.24
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| TNGXTango Therapeutics Inc. | $4B | $62.4M | -162.86% | -$0.87 | +1.68% | Buy |
| INDVIndivior Pharmaceuticals Inc. Common Stock | $4.1B | $1.2B | +16.95% | $1.64 | -0.09% | Buy |
| TLXTelix Pharmaceuticals Limited American Depositary Shares | $3.8B | $803.8M | -0.89% | -$0.0211 | -5.21% | Buy |
| MANEVeradermics Incorporated Common Stock | $4.1B | $0.00 | — | -$111.91 | +0.87% | Buy |
| VKTXViking Therapeutics Inc. Common Stock | $3.7B | $0.00 | — | -$3.19 | -0.47% | Buy |